Differences in the Expression of Apoptotic Proteins in Burkitt's Lymphoma Cell Lines: Potential Models for Screening Apoptosis-Inducing Agents

References

• Balint, E.E. and Vousden, K.H. (2001) "Activation and activities of the p53 tumour suppressor protein", British Journal of Cancer, 85, 1813 —1823.
   Web of Science ®Google Scholar
• Ashkenazi, A. and Dixit, V.M. (1999) "Death receptors: signaling and modulation", Science, 281, 1305–1308.
   Google Scholar
• Sheridan, J.P., Marsters, S.A., Pitti, R.M., Gurney, A., Skutbatch, M., Baldwin, D., et al. (1997) "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors", Science, 277, 818–821.
   Google Scholar
• Peter, M.E. and Krammer, P.H. (1998) "Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis", Current Opinion in Immunology, 5, 545–551.
   PubMed Web of Science ®Google Scholar
• Koncz, G., Bodor, C., Kovesdi, D., Gati, R. and Sarmay, G. (2002) "BCR mediated signal transduction in immature and mature B cells", Immunological Letters, 82, 41 — 49.
   Google Scholar
• Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsako-poulou, V., Ross, A.J., et al. (2001) "Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death", Science, 292, 727–730.
   PubMed Web of Science ®Google Scholar
• Zou, H., Li, Y., Liu, X. and Wang, X. (1999) "An APAF-1-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9", Journal of Biological Chemistry, 274, 11549–11556.
   PubMed Web of Science ®Google Scholar
• Debatin, KM., Poncet, D. and Kroemer, G. (2002) "Chemother-apy: targeting the mitochondrial cell death pathway", Oncogene, 21, 8786–8803.
   Google Scholar
• Sun, X.M., Bratton, S.B., Butterworth, M., MacFarlane, M. and Cohen, G.M. (2002) "Bc1-2 and Bc1-X1 inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein", Journal of Biological Chemistry, 277, 11345–11351.
   PubMed Web of Science ®Google Scholar
• Roy, N., Deveraux, Q.L., Takahashi, R., Salvesan, G.S. and Reed, J.C. (1997) "The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases", The EMBO Journal, 16, 6914— 6925.
   Google Scholar
• Ambrosini, G., Adida, C. and Altieri, D.C. (1997) "A novel anti-apoptotic gene, surviving, expressed in cancer and lymphoma", Nature Medicine, 3, 917–921.
   Google Scholar
• Klumpp, S. and Krieglstein, J. (2002) "Serine/threonine protein phosphatases in apoptosis", Current Opinion in Cancer, 2, 458–462.
   PubMed Web of Science ®Google Scholar
• Shohat, G., Spivak-Kroizman, T., Eisenstein, M. and Kimchi, A. (2002) "The regulation of death-associated protein (DAP) kinase in apoptosis", European Cytokine Network, 13, 387–395.
   Google Scholar
• Boldt, S., Weidle, U.H. and Kolch, W. (2002) "The role of MAPK pathways in the action of chemotherapeutic drugs", Carcinogen esis, 23, 1831–1838.
   Google Scholar
• Li, W. and Bertino, J.R. (2002) "Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase", Molecular Cancer Therapy, 1, 1343 — 1348.
   Google Scholar
• Swart, J.M. and Chiles, T.C. (2000) "Rescue of CH31 B cells from antigen receptor-induced apoptosis by inhibition of p38 MAPK", Biochemistry and Biophysical Research Communications, 276, 417 — 421.
   Google Scholar
• Ogata, S., Takeuchi, M., Fujita, H., Shibata, K., Okumura, K. and Taguchi, H. (2000) "Apoptosis induced by niacin-related com-pounds in K562 cells but not in normal human lymphocytes", Bioscience Biotechnology and Biochemistry, 64, 1142–1146.
   PubMed Web of Science ®Google Scholar
• Lecureur, V., Le Thiec, A., Le Meur, A., Amiot, L., Drenou, B., Bernard, M., et al. (2002). "Potassium antimonyl tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cells", British Journal of Haematology, 119, 608— 615.
   Google Scholar
• Tsan, M.F., White, J.E., Maheshwari, J.G. and Chikkappa, G. (2002) "Anti-leukemia effect of resveratrol", Leukemia and Lym-phoma, 43, 983–987.
   PubMed Web of Science ®Google Scholar
• Baell, J.B. and Huang, D.C. (2002) "Prospects for targeting the Bel-2 family of proteins to develop novel cytotoxic drugs", Biochemical Pharmacology, 64, 851 — 863.
   Google Scholar
• Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., et al. (1991) "p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia", Proceedings of the National Academy of Sciences, 88, 5413 — 5417.
   Google Scholar
• Drexler, H.G., Fombonne, S., Matsuo, Y., Hu, Z.B., Hamaguchi, H. and Uphoff, C.C. (2000) "p53 alterations in human leukemia-lymphoma cell lines: vitroartifact or prerequisite for cell immorta-lization?" Leukemia, 14, 198–206.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., Medema, J.P., Krammer, P.H. and Peter, M.E. (1997) "Flice is predominantly expressed as two functionally active isoforms, Caspase 8/a and Caspase 8/b", Journal Biological Chemistry, 272, 26953–2695.
   PubMed Web of Science ®Google Scholar
• Bae, J., Leo, C.P., Hsu, S.Y. and Hseueh, J.W. (2000) "MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a pro-apoptotic protein possessing only the BH3 domain", Journal of Biological Chemistry, 275, 25255 — 25261.
   Google Scholar
• Gutierrez, MI., Cherney, B., Hussain, A., Mostowski, H., Tosato, G., et al. (1999) "Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis", Cancer Research, 59, 696–703.
   Google Scholar
• Meijerink, J.P., Mensink, E.J., Wang, K., Sedlak, T.W., Sloetjes, A.W., de Witte, T., et al. (1998) "Hematopoetic malignancies demonstrate loss-of-function mutations of Bax", Blood, 9, 2991 — 2997.
   Google Scholar
• Korsmeyer, Si., Wei, M.C., Saito, M., Weiler, S., Oh, K.J. and Schlesinger, P.H. (2000) "Pro-apoptotic cascade activates BID, which oligomerizes BAK BAX into pores that result in the release in cytochrome c", Cell Death and Differentiation, 7, 1166–1173.
   Google Scholar
• Shiramizu, B., Barriga, F., Neequaye, J., Jafri, A., Dalla-Favera, R., Neri, A., et al. (1991) "Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association", Blood, 77, 1516–1526.
   PubMed Web of Science ®Google Scholar
• Bhatia, K.G., Gutierrez, MI., Huppi, K., Siwarski, D. and Magrath, I.T. (1992) "The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors", Cancer Research, 52, 4273–4276.
   PubMed Web of Science ®Google Scholar
• O'Connor, P.M., Jackman, J., Jondle, D., Bhatia, K., Magrath, I. and Kohn, K.W. (1993) "Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines", Cancer Research, 53, 4776–4780.
   PubMed Web of Science ®Google Scholar
• Hussain, A., Doucet, J.P., Gutiérrez, MI., Ahmad, M., Al-Hussein, K., Capello, D., et al. (2003) "Tumor necrosis factor Related Apoptosis Inducing Ligand (TRAIL) and Fas apoptosis in Burkitt's lymphomas with loss of multiple pro-apoptotic proteins", Haema-tologica, 88, 167–175.
   Google Scholar
• Eggert, A., Grotzer, M.A., Zuzak, T.J., Wiewrodt, B.R., Ho, R., Ikegaki, N. et al. (2001) "Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuro-blastoma cells correlates with a loss of caspase-8 expression", Cancer Research, 61, 1314–1319.
   PubMed Web of Science ®Google Scholar